pharmaceutical-engineering july-august-2023 agile-data-driven-life-cycle-management-continuous 
ISPE
JULY 6, 2023
This article provides a review on the current state of CM implementation, offers insights into life cycle management and regulatory aspects, and explains how a data- and knowledge-centric approach to risk management can help CM achieve its full potential. This is demonstrated by the rise from $1.05
ISPE
JANUARY 8, 2023
In this article, we elaborate on the benefits and requirements on xAI from a GxP point of view, along with the development and production process, with a focus on strategies to ensure that the intention of use is met and to manage risks for safety that arise from xAI itself. Pharmaceutical Engineering 42, no. Heitmann, and A.
Expert insights. Personalized for you.
52 
Let's personalize your content